RQx Pharmaceuticals, Inc. — Form D/A
RQx Pharmaceuticals, Inc. of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2011-02-17. The offering totals $7.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-02-17
- Form: D/A
- Accession: 0001507544-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $7.0M
- Amount sold: $1.2M
- Remaining: $5.8M
- Investors: 3
- Date of first sale: 2011-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151693
Issuer
- Name: RQx Pharmaceuticals, Inc.
- CIK: 0001507544
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 11099 N. TORREY PINES ROAD, LA JOLLA, CA, 92037
- Phone: (858) 768-7826
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jay A Litcher | Director | La Jolla, CA |
| Floyd A Romesberg | Director | La Jolla, CA |
| Court R Turner | Director | La Jolla, CA |
| THOMAS A COLL | Executive Officer | SAN DIEGO, CA |
| Douglas R Downs | Executive Officer | La Jolla, CA |
| Court R Turner | Executive Officer | La Jolla, CA |
Other filings by this issuer (1)
More